These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
568 related articles for article (PubMed ID: 18405144)
1. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes. Inzucchi SE Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144 [No Abstract] [Full Text] [Related]
2. Current and emerging therapies: an overview of incretin-based therapy in the management of type 2 diabetes. Pratley RE J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():7-11. PubMed ID: 19402254 [No Abstract] [Full Text] [Related]
3. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? Standl E; Schnell O Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474 [No Abstract] [Full Text] [Related]
4. Beyond glycemic control: the effects of incretin hormones in type 2 diabetes. Martin CL Diabetes Educ; 2008; 34 Suppl 3():66S-72S. PubMed ID: 18525067 [TBL] [Abstract][Full Text] [Related]
5. Which oral agent to use when metformin is no longer effective? Bannon M QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402 [No Abstract] [Full Text] [Related]
6. Diabetes under control: Understanding oral antidiabetic agents. Longo R Am J Nurs; 2010 Feb; 110(2):49-52. PubMed ID: 20107402 [No Abstract] [Full Text] [Related]
7. [Pharmacologic treatment of diabetes]. De Montigny P; Clerc C; Descarpentries C Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094 [No Abstract] [Full Text] [Related]
8. Clinical decisions. Management of type 2 diabetes. Goldberg RB; Holman R; Drucker DJ N Engl J Med; 2008 Jan; 358(3):293-7. PubMed ID: 18199869 [No Abstract] [Full Text] [Related]
9. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control. Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153 [No Abstract] [Full Text] [Related]
10. The backbone of oral glucose-lowering therapy: time for a paradigm shift? Seufert J Fundam Clin Pharmacol; 2009 Dec; 23(6):651-67. PubMed ID: 19469803 [TBL] [Abstract][Full Text] [Related]
11. [Incretin strategy in the treatment of type 2 diabetes mellitus--the DPP-IV inhibitor sitagliptin]. Perusicová J Vnitr Lek; 2007 Oct; 53(10):1109-13. PubMed ID: 18072437 [TBL] [Abstract][Full Text] [Related]
12. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors. Mathieu C; Bollaerts K Int J Clin Pract Suppl; 2007 Aug; (154):29-37. PubMed ID: 17593275 [TBL] [Abstract][Full Text] [Related]
13. Incretins: the novel therapy of type 2 diabetes. Thongtang N; Sriwijitkamol A J Med Assoc Thai; 2008 Jun; 91(6):943-54. PubMed ID: 18697398 [TBL] [Abstract][Full Text] [Related]
14. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm. Bailey T Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074 [TBL] [Abstract][Full Text] [Related]
15. Incretin-based therapy compared with non-insulin alternatives in elderly patients with type 2 diabetes. Zhao Q; Marcy TR Consult Pharm; 2013 Aug; 28(8):515-8. PubMed ID: 23906896 [TBL] [Abstract][Full Text] [Related]
16. What to add in with metformin in type 2 diabetes? Petrie JR; Adler A; Vella S QJM; 2011 Mar; 104(3):185-92. PubMed ID: 21156663 [TBL] [Abstract][Full Text] [Related]
17. beta-cell function and anti-diabetic pharmacotherapy. Del Prato S; Bianchi C; Marchetti P Diabetes Metab Res Rev; 2007 Oct; 23(7):518-27. PubMed ID: 17883249 [TBL] [Abstract][Full Text] [Related]
19. Use of noninsulin antidiabetic medications in hospitalized patients. Kopecky C Crit Care Nurs Clin North Am; 2013 Mar; 25(1):39-53. PubMed ID: 23410645 [TBL] [Abstract][Full Text] [Related]
20. Insulin initiation in Type 2 diabetes. Page S Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011 [No Abstract] [Full Text] [Related] [Next] [New Search]